`Border, Scott; Trials
`megan.raymond@groombridgewu.com; Novo-Semaglutide-IPR@groombridgewu.com; Wong, Jovial
`RE: Petition IPR2024-00009 challenging 10,335,462
`Tuesday, February 13, 2024 11:34:15 AM
`
`From:
`To:
`Cc:
`Subject:
`Date:
`
`Counsel,
`
`The parties are authorized the additional briefing as outlined in the e-mail below.
`
`Regards,
`
`Esther Goldschlager
`Supervisory Paralegal Specialist
`Patent Trial & Appeal Board
`U.S. Patent & Trademark Office
`
`From: Border, Scott <SBorder@winston.com>
`Sent: Tuesday, February 13, 2024 9:51 AM
`To: Trials <Trials@USPTO.GOV>
`Cc: megan.raymond@groombridgewu.com; Novo-Semaglutide-IPR@groombridgewu.com; Wong,
`Jovial <JWong@winston.com>
`Subject: Petition IPR2024-00009 challenging 10,335,462
`
`CAUTION: This email has originated from a source outside of USPTO. PLEASE CONSIDER THE SOURCE before
`responding, clicking on links, or opening attachments.
`
`Your Honors,
`
`The Petitioner requests authorization pursuant to 37 C.F.R. §42.108(c) to file a reply to Patent
`Owner’s Preliminary Patent Owner Response limited to 3-pages and specifically addressing Patent
`Owner’s arguments related to § 314(a)/Fintiv and § 315, for which good cause exists because
`Petitioner could not have foreseen the arguments raised with respect to those issues. The Petitioner
`proposes to file its reply on or by February 21, 2024.
`
`In addition, the Patent Owner requests authorization to file a 3-page sur-reply to Petitioner’s reply
`and will do so within two weeks of Petitioner’s filing.
`
`The parties have met and conferred and to avoid unnecessarily burdening the Board with a dispute
`on these issues have agreed to this course of action subject to the Board’s authorization, and we are
`generally available this week at the Board’s convenience for a conference call if necessary.
`
`Respectfully,
`
`Scott Border
`Counsel for Petitioner
`
`Exhibit 3001
`
`
`
`
`
`Scott Border
`Partner
`Winston & Strawn LLP
`1901 L Street, N.W.
`Washington, D.C. 20036-3506
`D: +1 202-282-5054
`M: +1 703-899-4136
`Bio | VCard | Email | winston.com
`
`Any tax advice contained in this email was not intended to be used, and cannot be used, by you (or any other taxpayer) to avoid penalties
`under applicable tax laws and regulations.
`
`
`
`The contents of this message may be privileged and confidential. If this message has been received in error, please delete it without
`reading it. Your receipt of this message is not intended to waive any applicable privilege. Please do not disseminate this message without
`the permission of the author. Any tax advice contained in this email was not intended to be used, and cannot be used, by you (or any
`other taxpayer) to avoid penalties under applicable tax laws and regulations.
`
`